A Look At Merit Medical Systems (MMSI) Valuation After Strong Q3 Beat And Cautious Full Year Guidance

Simply Wall St.

Feb 07

Merit Medical Systems (MMSI) has drawn fresh attention after reporting third quarter revenue growth of 13% year on year, beating analysts’ organic and overall revenue estimates while pairing that ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2609526319"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2609526319\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2609526319?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","is_english":true,"pubTime":"2026-02-07 23:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2609526319","market":"hk","top_or_hot":-1,"title":"A Look At Merit Medical Systems (MMSI) Valuation After Strong Q3 Beat And Cautious Full Year Guidance","media":"Simply Wall St.","content":"<div>\n<p>Merit Medical Systems (MMSI) has drawn fresh attention after reporting third quarter revenue growth of 13% year on year, beating analysts’ organic and overall revenue estimates while pairing that ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-mmsi/merit-medical-systems/news/a-look-at-merit-medical-systems-mmsi-valuation-after-strong\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At Merit Medical Systems (MMSI) Valuation After Strong Q3 Beat And Cautious Full Year Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At Merit Medical Systems (MMSI) Valuation After Strong Q3 Beat And Cautious Full Year Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-07 23:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-mmsi/merit-medical-systems/news/a-look-at-merit-medical-systems-mmsi-valuation-after-strong><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merit Medical Systems (MMSI) has drawn fresh attention after reporting third quarter revenue growth of 13% year on year, beating analysts’ organic and overall revenue estimates while pairing that ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-mmsi/merit-medical-systems/news/a-look-at-merit-medical-systems-mmsi-valuation-after-strong\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0566484027.USD","symbol_name":"安本美国小盘成长股","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-mmsi/merit-medical-systems/news/a-look-at-merit-medical-systems-mmsi-valuation-after-strong","article_id":"2609526319","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-mmsi/merit-medical-systems/news/a-look-at-merit-medical-systems-mmsi-valuation-after-strong","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2609526319","pubTimestamp":1770477036,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Merit Medical Systems (MMSI) has drawn fresh attention after reporting third quarter revenue growth of 13% year on year, beating analysts’ organic and overall revenue estimates while pairing that result with the weakest full-year guidance among peers.\nSee our latest analysis for Merit Medical Systems.\nAt a share price of US$82.50, Merit Medical Systems has seen a 3.60% 1 day share price return and a 1.74% 7 day share price return, but a 24.40% decline in 1 year total shareholder return...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0566484027.USD":"安本美国小盘成长股","LU1559883803.SGD":"Aberdeen Standard SICAV I - North American Smaller Companies Fund A Acc SGD-H","BK4198":"医疗保健用品","MMSI":"Merit Medical Systems"},"translate_title":"在第三季度强劲表现和谨慎的全年指引之后，看看Merit Medical Systems(MMSI)的估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MMSI":1.5},"content_text":"Merit Medical Systems (MMSI) has drawn fresh attention after reporting third quarter revenue growth of 13% year on year, beating analysts’ organic and overall revenue estimates while pairing that result with the weakest full-year guidance among peers. See our latest analysis for Merit Medical Systems. At a share price of US$82.50, Merit Medical Systems has seen a 3.60% 1 day share price return and a 1.74% 7 day share price return, but a 24.40% decline in 1 year total shareholder return suggests recent momentum has faded despite positive multi year total shareholder returns. If this earnings update has you thinking about where growth could come from next in healthcare, it might be worth checking out 26 healthcare AI stocks as a starting list of ideas. With revenue growth running ahead of expectations, a forward P/E of 20.4x and the share price sitting below the average analyst target, the key question is whether this pullback reveals value or if the market is already pricing in future growth. AdvertisementMost Popular Narrative: 20.3% Undervalued The most followed narrative currently puts Merit Medical Systems' fair value at $103.55 compared with the last close of $82.50, and it builds that gap on a detailed view of procedure growth, margins and capital allocation.  The expanding global prevalence of chronic diseases and an aging population are increasing the need for interventional, diagnostic, and therapeutic medical procedures. Merit's strong growth in cardiovascular and endoscopy segments, robust new product development, and recent acquisitions (such as Biolife and EndoGastric) position the company to capture a larger share of this growing market and drive sustained long-term revenue growth.  Read the complete narrative. Read the complete narrative. Want to see what turns that story into a double digit discount estimate? The narrative leans heavily on expanding margins, steady top line gains and a richer earnings base by 2028. The exact mix of revenue growth, profitability and the valuation multiple on those future earnings might surprise you. On the numbers behind that narrative, analysts are building in consistent revenue growth, higher profit margins and a meaningfully larger earnings pool over the next few years, all discounted back at 7.7% to reach a present fair value of $103.55. The result is a view that Merit Medical Systems is currently trading at a discount to those implied future cash flows and earnings power, with the narrative hinging on execution in cardiovascular and endoscopy as well as successful integration of acquired product lines. Result: Fair Value of $103.55 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, that story can easily change if WRAPSODY reimbursement delays drag on or if tariffs and trade tensions push costs higher and squeeze margins. Find out about the key risks to this Merit Medical Systems narrative. Another View: Rich Multiples Temper The Undervaluation Story That 20.3% undervalued fair value hinges on future earnings power, but today Merit trades on a P/E of 41.3x. That is well above the US Medical Equipment industry at 30.7x, peers at 26.2x and a fair ratio of 24.5x. Is the current price already baking in a lot of optimism? See what the numbers say about this price — find out in our valuation breakdown. NasdaqGS:MMSI P/E Ratio as at Feb 2026 Build Your Own Merit Medical Systems Narrative If you look at the numbers and reach a different conclusion, or simply prefer to build on your own research, you can pull the data together and shape a custom view for Merit Medical Systems in just a few minutes. You can then pressure test it against the market using our tools, all starting with Do it your way A great starting point for your Merit Medical Systems research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision. Looking for more investment ideas? If this has sharpened your thinking on Merit, do not stop here. The screener can quickly surface other opportunities that might fit your style and risk tolerance.  Target reliable cash generators by scanning for 14 dividend fortresses that may suit an income focused portfolio. Hunt for potential bargains using our 53 high quality undervalued stocks as a way to spot ideas with attractive fundamentals. Prioritise resilience by checking companies in the 86 resilient stocks with low risk scores if you want business quality front and center.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}